Skip to content
HowShorted

Alaunos Therapeutics, Inc. short interest in 2019

In 2019, Alaunos Therapeutics, Inc.'s disclosed short interest ran from 28.52% of shares outstanding on 15 Jan 2019 to 29.20% on 31 Dec 2019, a change of +0.68 percentage points. The year's high was 31.08% on 15 Oct 2019 and its low 25.28% on 31 May 2019, averaging 28.31% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 44.25 days on 15 Oct 2019. Full history: Alaunos Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Alaunos Therapeutics, Inc. in 2019

2019 in figures

Start of year
28.52% (15 Jan 2019)
End of year
29.20% (31 Dec 2019)
Change
+0.68 pp
High
31.08% (15 Oct 2019)
Low
25.28% (31 May 2019)
Average
28.31%
Highest days to cover
44.25 (15 Oct 2019)
SEC filings marked
8

Every report in 2019

Alaunos Therapeutics, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201928.52%26.15
31 Jan 201928.48%25.81
15 Feb 201928.95%35.47
28 Feb 201929.38%24.52
15 Mar 201928.54%19.2410-K filed, results (8-K)
29 Mar 201929.02%18.30
15 Apr 201929.57%25.55
30 Apr 201925.45%31.17
15 May 201925.48%29.6610-Q filed, results (8-K)
31 May 201925.28%39.03
14 Jun 201926.01%18.58
28 Jun 201927.41%12.45
15 Jul 201929.12%29.63
31 Jul 201926.84%26.53
15 Aug 201928.31%21.2010-Q filed, results (8-K)
30 Aug 201928.31%24.64
13 Sep 201928.65%30.48
30 Sep 201930.20%26.45
15 Oct 201931.08%44.25
31 Oct 201928.05%34.26
15 Nov 201928.99%41.4010-Q filed, results (8-K)
29 Nov 201929.31%32.38
13 Dec 201929.27%38.17
31 Dec 201929.20%31.20

See also: Alaunos Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.